Feb/March 2019 Edition

We welcome you to come and read through our latest, Feb/March, edition of Modern Medicine.

This month we have a jam packed edition for you. Our features this month include;General Practice, Contraception, Pain and many more.

We encourage all of our readers to complete the CPD questionnaire for this edition, this can be done on the answer-form included in the magazine, or on our website CPD system.

Modern Medicine, the journal that’s with you wherever you go.

Osteoarthritis, Moving Beyond Ageing

Osteoarthritis, Moving Beyond Ageing

Osteoarthritis is a heterogeneous group of diseases characterised by pain and loss of function, and is a leading cause of disability worldwide. Although risk factors vary across joints, common factors include obesity and advancing age. A largely clinical diagnosis, management for symptomatic disease is centred on nonpharmacological and nonsurgical measures. Pharmacotherapy is ideally limited to the treatment of acute flares of pain with joint replacement being reserved for advanced symptomatic disease.

Modern Medicine – Feb/March 2019

The Discharging Ear A Good History Tells the Story

The Discharging Ear A Good History Tells the Story

A significant number of discharging ear conditions can be diagnosed through taking a history, with the type of discharge (purulent, clear or blood-stained) often signalling the aetiology. Classifying the type of discharge present allows the various common aetiologies to be considered, enabling accurate treatment or referral of the patient.

Modern Medicine – Feb/March 2019

Echinacea’s Potent Antiviral Activities

Echinacea’s Potent Antiviral Activities

Various studies have revealed that certain standardised preparations of Echinacea purpurea (EP) contain potent and selective antiviral and antimicrobial activities. In addition, they display multiple immunemodulatory activities, comprising stimulation of certain immune functions such as phagocytic activity of macrophages and suppression of the proinflammatory responses of epithelial cells to viruses and bacteria, which are manifested as alterations in secretion of various cytokines and chemokines.

Modern Medicine – Feb/March 2019

Heavy Menstrual Bleeding Treatment and referral options

Heavy Menstrual Bleeding Treatment and referral options

Heavy menstrual bleeding affects about one in four women. Comprehensive assessment is essential to determine the likely cause of the bleeding and its impact on a woman’s life; it includes exclusion of anaemia, iron deficiency and reproductive tract cancer. After excluding malignancy, first-line management in primary care is with pharmaceutical treatments. Other treatment options include endometrial ablation and hysterectomy.

Modern Medicine – Feb/March 2019